“Bimekizumab Safety in Patients With Moderate to Severe Plaque Psoriasis: Analysis of Pooled Data from up to Three Years of Treatment in Phase 2 and 3 Clinical Trials”. SKIN The Journal of Cutaneous Medicine 6, no. 6 (November 16, 2022): s66. Accessed March 15, 2026. https://skin.dermsquared.com/skin/article/view/1821.